Table 1.
Human leptin variant | Residue # after signal peptide cleavage | Publication | Impact | RUSH results |
Additional details | |
---|---|---|---|---|---|---|
Expression | Secretion | |||||
G59S | G38S | Bouafi et al., Biomed Res Int. 2019 (43); Funcke, J et al. N. Engl. J. Med. 2023 (16) |
Reduced receptor affinity | ↔ | ↔ | Possible reduction in secretion |
L72S | L51S | Fischer-Posovszky et al., J Clin Endocrinol Metab. 2010 (25) | Undetectable serum leptin | ↓↓↓↓ | N/A (low expression) | Proteasomal degradation |
N103K | N82K | Mazen et al., Mol Genet Metab. 2009; (26) Bouafi et al., Biomed Res Int. 2019 (43) |
Reduced serum leptin | ↔ | ↔ | No effect found |
R105W | R84W | Strobel et al.,Nat Genet. 1998; (12) Saeed et al.,Obesity. 2015; (27) Bouafi et al., Biomed Res Int. 2019 (43) |
Reduced/undetectable serum leptin | ↓↓↓↓ | N/A (low expression) | Proteasomal degradation |
C117Y | C96Y | Saeed et al.,Obesity. 2015; (27) Bouafi et al., Biomed Res Int. 2019 (43) |
Undetectable serum leptin | ↓↓↓↓ | N/A (low expression) | Proteasomal degradation |
H118L | H97L | Zhao et al., Biomed Res Int. 2014 (30) | No data | ↔ | ↔ | Possible reduction in expression and secretion |
P23R | P2R | Murray et al., Eur J Endocrinol. 2011 (28) | Reduced serum leptin (possibly confounded by decreased antibody binding) | ↔ | ↔ | No effect found |
P64S | P43S | Funcke, J et al. N. Engl. J. Med. 2023 (16) | Reduced receptor affinity | ↔ | ↔ | No effect found |
D100Y | D79Y | Wabitsch et al., N Eng J Med. 2015 (13) | Reduced receptor affinity | ↔ | ↔ | No effect found |
D100N | D79N | Bouafi et al., Biomed Res Int. 2019 (43); Saeed et al., Diabates. 2020 (31) | No data | ↔ | ↔ | Possible reduction in expression |
V110M | V89M | Echwald et al., Int J Obesity. 1997 (32) | No effect on serum leptin | ↔ | ↔ | No effect found |
S141C | S120C | Chekhranova et al., Bioorg Khim. 2008 (29) | No data | ↔ | ↓↓↓↓ | Secretion reduction by approximately 50% |